Brainstorm Cell Therapeutics, Inc.: A Small Biotech With Big Plans And Huge Potential
- Stem cell therapies are finally entering human trials, and initial results are validating the science and providing hints of strong efficacy.
- StemCells, Inc. was an obvious investment opportunity, based on the four Cs of biotech investing. Brainstorm Cell Therapeutics, based on the same set of criteria, will follow suit.
- With a recent capital raise, Brainstorm is poised to deliver results from its Phase II ALS trial, which will drive appreciation in stock value.